<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02038088</url>
  </required_header>
  <id_info>
    <org_study_id>LKZ-GAHBV-01</org_study_id>
    <nct_id>NCT02038088</nct_id>
  </id_info>
  <brief_title>The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication</brief_title>
  <acronym>HBV</acronym>
  <official_title>The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lu KZ</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southwest Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the general anesthesia immunosuppressive&#xD;
      could effect hepatitis B Virus replication&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The change of immune state can influence HBV replication or elimination, it has been reported&#xD;
      that a certain degree of immunosuppression occured after general anesthesia. In this study we&#xD;
      detect the cytotoxic T lymphocyte(CTL) count and activity, interferon-γ(IFN-γ) and HBV-DNA&#xD;
      content form the HBV patient who will accept general anesthesia. Our purpose is to evaluate&#xD;
      the influence of general anesthesia immunosuppressive on HBV replication. If the results show&#xD;
      that HBV-DNA quantity increases, so the patients might be given anti-HBV drugs or immune&#xD;
      enhancer; otherwise it is indicated the general anesthesia immunosuppressive don't influence&#xD;
      HBV replication.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>4 Days</target_duration>
  <primary_outcome>
    <measure>HBV-DNA</measure>
    <time_frame>with in the first 5 days after surgery</time_frame>
    <description>collect blood samples 4 times with in the first 5 days after surgery:&#xD;
the first time：before initiation of anesthesia; the second time：the first day after surgery; the third time：the third day after surgery; the forth time：the fifth day after surgery.&#xD;
And outcome measure will be assessed with in 3 months when all the samples collected, and will be presented with in 2 months when outcome measure assessed .</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>HBV Infection</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <description>intravenous inhalational anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <description>intravenous anesthesia</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with HBV infection receive surgery under general anesthesia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. American Society of Anesthesiologists（ASA） Ⅰ - Ⅱ;&#xD;
&#xD;
          2. ability to compliance the research plan;&#xD;
&#xD;
          3. volunteered and signed for the study ;&#xD;
&#xD;
          4. HBsAg positive, no serious system disease (heart: New York Heart Association（NYHA）&#xD;
             class Ⅰ - Ⅱ, lung: vital capacity（VC）% or maximal voluntary ventilation（MVV）%&gt;71,&#xD;
             forced expiratory volume at one second（FEV1.0）%&gt;61, arterial oxygen&#xD;
             saturation（SaO2）%&gt;94, arterial partial pressure of oxygen（PaO2）&gt;75 mmHg, arterial&#xD;
             carbondioxide partial pressure（PaCO2）&lt;45mmHg, liver:child-pugh class A - B and kidney:&#xD;
             chronic kidney disease（CKD）stage 1-3);&#xD;
&#xD;
          5. receive under general anesthesia (including gynecology, orthopedics,general surgery&#xD;
             and urology department).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. ASA&gt;Ⅱ;&#xD;
&#xD;
          2. tumor patients&#xD;
&#xD;
          3. can't collaborate;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lu KZ, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Anesthesiology, Southwest Hospital Third Military Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, Southwest Hospital Third Military Medical University</name>
      <address>
        <city>ChongQing</city>
        <state>Chongqing</state>
        <zip>400000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <study_first_submitted>January 13, 2014</study_first_submitted>
  <study_first_submitted_qc>January 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2014</study_first_posted>
  <last_update_submitted>January 27, 2015</last_update_submitted>
  <last_update_submitted_qc>January 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Southwest Hospital, China</investigator_affiliation>
    <investigator_full_name>Lu KZ</investigator_full_name>
    <investigator_title>Southwest Hospital</investigator_title>
  </responsible_party>
  <keyword>Need general anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis B</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

